We are live on ! Find out more
ASXC

Asensus Surgical, Inc.

Delisted

ASXC was delisted on the 21st of August, 2024.

95 hedge funds and large institutions have $89.7M invested in Asensus Surgical, Inc. in 2018 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 13

32% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 19

12% more funds holding

Funds holding: 8595 (+10)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

12% less capital invested

Capital invested by funds: $101M → $89.7M (-$11.7M)

12% less call options, than puts

Call options by funds: $1.44M | Put options by funds: $1.64M

Holders
95
Holders Change
+10
Holders Change %
+11.76%
% of All Funds
2.18%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
23
Increased
25
Reduced
19
Closed
13
Calls
$1.44M
Puts
$1.64M
Net Calls
-$202K
Net Calls Change
-$745K
Name Holding Trade Value Shares
Change
Change in
Stake
AC
1
Aisling Capital
New York
$16.8M
SHI
2
SV Health Investors
Massachusetts
$12.8M
JP Morgan Chase
3
JP Morgan Chase
New York
$12.4M +$267K +11,687 +2%
Vanguard Group
4
Vanguard Group
Pennsylvania
$9.56M +$691K +30,194 +8%
MCM
5
Masters Capital Management
Georgia
$6.8M +$220K +9,615 +3%
SG
6
StepStone Group
California
$5.16M
Millennium Management
7
Millennium Management
New York
$3.22M +$2.96M +129,352 +787%
BlackRock
8
BlackRock
New York
$2.96M -$39K -1,706 -1%
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$2.57M +$983K +42,968 +58%
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$1.98M +$218K +9,544 +12%
Goldman Sachs
11
Goldman Sachs
New York
$1.64M +$1.67M +72,778 +5,391%
UBS Group
12
UBS Group
Switzerland
$1.54M +$1.5M +65,749 +1,658%
IBT
13
International Biotechnology Trust
United Kingdom
$1.5M
Geode Capital Management
14
Geode Capital Management
Massachusetts
$1.14M
PVAM
15
Pacific View Asset Management
California
$883K +$306K +13,379 +50%
LCM
16
Laurion Capital Management
New York
$866K +$896K +39,169 New
TEE
17
Tibra Equities Europe
United Kingdom
$570K +$591K +25,813 New
EAM
18
Eagle Asset Management
Florida
$531K +$551K +24,068 New
Northern Trust
19
Northern Trust
Illinois
$455K +$60.3K +2,637 +15%
SM
20
Sabby Management
Florida
$436K -$794K -34,722 -64%
Group One Trading
21
Group One Trading
Illinois
$431K +$334K +14,609 +298%
Deutsche Bank
22
Deutsche Bank
Germany
$373K +$385K +16,833 +16,186%
ECM
23
Element Capital Management
New York
$344K +$356K +15,570 New
California Public Employees Retirement System
24
California Public Employees Retirement System
California
$274K
LPL Financial
25
LPL Financial
California
$263K -$26.4K -1,154 -9%

ASXC Hedge Fund Activity: Q1 2018 in Review

95 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Asensus Surgical, Inc. (ASXC) for Q1 2018, worth a combined $89.7M — down 12% from $101M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new ASXC positions and 13 closed out — a net gain of 10 holders — while 25 added to existing stakes and 19 trimmed.

The largest buyer was Millennium Management, adding an estimated $2.96M. The largest seller was Redmile Group, exiting entirely with an estimated $9.68M sold.

  • 95 institutional investors held Asensus Surgical, Inc. (ASXC) as of Q1 2018, up from 85 in Q4 2017.
  • Funds reported $89.7M of Asensus Surgical, Inc. stock for Q1 2018, down 12% quarter-over-quarter.
  • 23 funds opened new Asensus Surgical, Inc. positions in Q1 2018 and 13 closed out, a net change of +10 holders.
  • The largest Asensus Surgical, Inc. buyer in Q1 2018 was Millennium Management, an estimated $2.96M added.
  • The largest Asensus Surgical, Inc. seller in Q1 2018 was Redmile Group, an estimated $9.68M sold.

Based on aggregated 13F filings for Q1 2018.